AstraZeneca plc buy Gilbert
Start price
20.01.21
/
60%
€87.23
Target price
20.01.22
-
Performance (%)
-1.82%
End price
29.03.21
€85.64
Summary
This prediction ended on 29.03.21 with a price of €85.64. With a performance of -1.82%, the BUY prediction by Gilbert finished with a loss. Dividends of €1.59 are taken into consideration when calculating the performance. Gilbert has 60% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y | 3y |
---|---|---|---|---|
AstraZeneca plc | -1.175% | -1.175% | 20.633% | 43.251% |
iShares Core DAX® | 0.786% | -0.427% | 17.458% | 17.620% |
iShares Nasdaq 100 | 2.297% | 7.331% | 38.189% | 53.439% |
iShares Nikkei 225® | 3.076% | 3.279% | 13.174% | 10.191% |
iShares S&P 500 | 0.902% | 3.970% | 29.787% | 46.282% |
According to Gilbert what are the pros and cons of AstraZeneca plc for the foreseeable future?
Pros
Small cyclical dependencies
Could be worthwhile Investment >10% per year
Standard Investments for future growth
Cons
Comments by Gilbert for this prediction
In the thread AstraZeneca plc diskutieren
Buy mit Kursziel 99,0
Kursziel geändert auf 0,0
Kursziel gesetzt auf 90,0
Kursziel geändert auf 95,0
Kursziel geändert auf 0,0
In the thread Trading AstraZeneca plc
Buy beendet